Annual inventory: Interpreting the development of the pharmaceutical equipment industry in 2021 from 4 key words

With a flick of a finger, there is only less than a month left before the ringing of the bell in 2022.
At present, many industries, enterprises and individuals have begun to prepare for the 2021 year-end summary and the 2022 work plan
.
Among them, it can be said that it is an interesting job to summarize the key words of the industry development.
By searching for the key words of the industry this year, it may help the industry to understand the pulse of the industry
.
So, what are the key words for the development of the pharmaceutical equipment industry this year? The author will interpret the development of the pharmaceutical equipment industry in 2021 from the four key words of digitalization, domestic substitution, green development, and internationalization
.
Pharmaceutical equipment (picture source: Pharmaceutical Network) Keyword 1: Digitization In the past few years, pharmaceutical robots often talk about the development of automation, intelligence, and digitization.
However, the ideal is very full, and the reality is very skinny, although many large-scale Pharmaceutical machinery companies have increased R&D investment in these new directions and achieved some innovative results.
However, most small and medium-sized enterprises still lack strength in the level of automation and informatization of pharmaceutical equipment
.
Affected by the epidemic since 2020, the traditional production model has been unable to meet the production capacity needs of pharmaceutical companies, which has forced pharmaceutical equipment companies to transform and upgrade
.
Entering 2021, new technologies including artificial intelligence and cloud computing are accelerating their penetration into manufacturing applications, and policies are also vigorously supporting the transformation and upgrading of manufacturing
.
In April 2021, the "Fourteenth Five-Year Plan for Intelligent Manufacturing Development" drafted by the Ministry of Industry and Information Technology in collaboration with relevant departments was released.
The document proposes that by 2025, manufacturing enterprises above designated size will be basically digitalized, and key industries in key industries will initially achieve intelligent transformation.

.
By 2035, manufacturing enterprises above designated size will be fully digitized, and backbone enterprises will basically realize intelligent transformation
.
This document undoubtedly released a big signal: the digitalization of the manufacturing industry will be supported
.
As an important part of the manufacturing industry, the digital transformation of the pharmaceutical equipment industry is also imminent
.
Since the beginning of this year, many pharmaceutical machinery companies have been actively embracing digitalization and speeding up their investment in digital upgrading and transformation.

.
For example, a pharmaceutical machine company uses a digital chromatography system to shorten the manufacturing cycle of pharmaceutical equipment hardware; there are also pharmaceutical equipment companies that are deeply engaged in the intelligent manufacturing of pharmaceutical equipment, through the acquisition and establishment of subsidiaries, and multiple layouts to build "smart and smart pharmaceutical factories" to speed up the process.
Enter the "Pharmaceutical Industry 4.
0 Era"
.
Through digital transformation, companies can improve management efficiency, reduce costs, and at the same time ensure drug quality and safety, and promote the development of the entire industry with higher quality
.
Key word two: domestic substitution.
2021 is the first year of the "14th Five-Year Plan".
According to the 14th Five-Year Plan and the 2035 long-term goal outline, innovation is an important content
.
Since the beginning of this year, pharmaceutical equipment companies are accelerating innovation, gradually moving from low-end to high-end, upgrading from a single equipment supplier to an overall solution
.
At the same time, domestic pharmaceutical machinery companies are speeding up the process of replacing imports with domestic products by strengthening innovative research and development when the delivery of imported equipment is delayed
.
In order to seize the huge market space for domestic substitution in the future, some pharmaceutical machinery companies are even more gearing up.
For example, in April this year, Chutian Technology issued an announcement saying that the company had recently bid for land through bidding and listing, and won the city of Ningxiang.
The real estate property certificate issued by the Natural Resources Bureau, the land will be used for the company's future capacity expansion
.
A research report released during the year pointed out that after ten years of industrial chain development, domestic pharmaceutical equipment companies have gradually become a subdivision of China’s high-end manufacturing, domestic substitution has accelerated, export overseas business has grown rapidly, and the industry has gradually faded away from its cyclical nature.
For long-term growth
.
Keyword three: green development In recent years, under the high pressure of environmental protection, the keyword green development has been mentioned in almost every high-polluting industry
.
The upstream of pharmaceutical equipment is one of the high-pollution industries, and the green and low-carbon requirements for production equipment are continuously increasing.
This has forced pharmaceutical machinery companies to continue to improve and upgrade their equipment to meet the environmental production needs of pharmaceutical companies
.
For example, this year a pharmaceutical machine company has specially developed a new combined multi-effect distilled water machine that can provide sterile pharmacy, injection, large infusion, and biological pharmacy for the pharmaceutical industry
.
The equipment can run continuously for 240 days, saving 65% energy in terms of water saving, industrial steam saving, and reduction of enterprise sewage pressure.

.
In November 2021, the two ministries and commissions issued the "Notice on Promoting the Implementation Plan Conducive to the High-quality Development of the Industry", proposing to develop a batch of high-value-added and high-growth varieties by 2025, make breakthroughs in a batch of green and low-carbon technology and equipment, and make breakthroughs in the industry.
The development bottleneck restricts and raises the level of independent supporting of the industrial chain
.
With the release of this plan, the importance of green development has become more and more prominent.
It is expected that relevant pharmaceutical machinery companies will further seize the opportunity and devote themselves to creating energy-saving, efficient, and environmentally friendly pharmaceutical equipment
.
Keyword 4: Internationalization Related data show that in recent years, the export value of the domestic pharmaceutical equipment industry has continued to grow, reaching about 2 to 3 billion yuan
.
In 2021, pharmaceutical companies with international business such as Chutian Technology, Tofflon and other companies have disclosed in the report that overseas performance has achieved a certain increase
.
At present, internationalization has become a major trend in the development of domestic pharmaceutical equipment companies, and is also regarded as a new growth point for the company's performance
.
In July of this year, Chutian Technology also stated in an agency survey that in the next 3-5 years, the company plans to maintain an annual increase of 10%-20% in its export business.
It is planned that the export business income of Chutian headquarters will account for the total income by about 2025.
40%-50%
of